Choose   Change
nifty-bgi-slide

NIFTY™ – Non-invasive pre-natal testing

During the last decade, developments in the science of genetics and enormous advances in genetic technologies have altered our capability to understand diseases, make diagnoses and provide effective treatments.

Transforming the world of prenatal testing, the advent of new DNA-based non-invasive prenatal testing (NIPT) has introduced a highly accurate screening strategy for fetal anueploidy. The NIFTY® test (Non-Invasive Fetal TrisomY test) was the first NIPT to enter clinical testing in 2010 and has been validated by a study on nearly 147,000 pregnancies.

Providing screening for the most common trisomies present at birth, as well as testing options for gender, sex chromosomal aneuploidies and chromosomal deletions, NIFTY® provides a significantly stronger risk indication than traditional screening procedures. As of 2015, over 500,000 NIFTY® tests have been carried out worldwide.

Visit www.niftytest.com for more information or email info@bgi.com to learn how you can become a provider.

Contact

Don’t hesitate to contact us to request a quote or to talk more about your requirements and how we can support your needs.


(+45) 80 300 800 (Europe)
(+1) 617 500 2741 (Americas)
(+852) 36103510 (Asia Pacific)
(+86) 755 25273698 (China)



BGI certificates

Regional Availability

Testing services not currently available in the United States of America. In some markets, testing services are offered for research use only. Please contact a representative for regional availability.

Copyright © BGI 2016